Akero Therapeutics (NASDAQ:AKRO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Akero Therapeutics (AKRO) operate in?

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Akero Therapeutics Stock (NASDAQ: AKRO) stock price, news, charts, stock research, profile.

Open	$28.40
Close	$28.56
Volume / Avg.	266.38K / 595.59K
Day Range	$28.02 - $28.79
52 Wk Range	15.32 - 37.00
Market Cap	$1.99B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	4.87%
Days to Cover	6.38

Recent News

Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Editas Q2 Earnings & Revenues Miss Estimates, Stock Down

Editas Medicine, Inc. (NASDAQ: EDIT) incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a loss of 56 cents per share in the year-ago quarter.

Zacks

This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's Q2 FY24 earnings report on August 8 will include a pre-tax IPR&D charge of $154 million, impacting GAAP and non-GAAP EPS by $0.14.

Shivani Kumaresan

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$28.40
Close	$28.56
Volume / Avg.	266.38K / 595.59K
Day Range	$28.02 - $28.79
52 Wk Range	15.32 - 37.00
Market Cap	$1.99B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	4.87%
Days to Cover	6.38

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Akero Therapeutics (AKRO) stock?

You can purchase shares of Akero Therapeutics (NASDAQ:AKRO) through any online brokerage.

View our list of the best stock brokerages

Who are Akero Therapeutics (AKRO) competitors?

Other companies in Akero Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT), Xencor (NASDAQ:XNCR) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Akero Therapeutics (AKRO) stock?

Akero Therapeutics has a consensus price target of $43.89.

What is the current price for Akero Therapeutics (AKRO)?

The stock price for Akero Therapeutics (NASDAQ: AKRO) is $28.56 last updated December 24, 2024 at 1:00 PM EST.

Does Akero Therapeutics (AKRO) pay a dividend?

There are no upcoming dividends for Akero Therapeutics.

When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?

Akero Therapeutics’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Is Akero Therapeutics (AKRO) going to split?

There is no upcoming split for Akero Therapeutics.

What sector and industry does Akero Therapeutics (AKRO) operate in?

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Akero Therapeutics

Akero Therapeutics (AKRO) Forecast